A 58-year-old male with cirrhosis presents with significant ascites, mild confusion, jaundice, and peripheral edema. Laboratory findings show decreased serum albumin, elevated bilirubin, elevated liver enzymes, prolonged INR, and high ammonia levels. Which nursing intervention is most appropriate to address the patient's hepatic encephalopathy?

B) Increase the dose of lactulose to reduce ammonia levels

A) Administer furosemide to reduce fluid retention

B) Increase the dose of lactulose to reduce ammonia levels

C) Provide a low-protein diet to minimize ammonia production

D) Prepare the patient for paracentesis to relieve ascites

A 58-year-old male with cirrhosis is admitted with significant ascites, mild confusion, jaundice, and peripheral edema. His lab results show decreased serum albumin, elevated bilirubin, elevated liver enzymes, and increased ammonia levels. Which nursing intervention is most important to address the patient's hepatic encephalopathy?

C) Administering lactulose to reduce ammonia levels

A) Administering diuretics to reduce ascites

C) Administering lactulose to reduce ammonia levels

D) Encouraging a high-protein diet to improve nutritional status

A patient with cirrhosis has developed spontaneous bacterial peritonitis (SBP) and is experiencing worsening hepatic encephalopathy. Which nursing intervention is most appropriate to address the patient's altered neurological status?

A) Administer a higher dose of lactulose to increase bowel movements.

B) Restrict fluid intake to prevent further ascites accumulation.

C) Position the patient in a semi-Fowler's position to enhance breathing.

D) Initiate seizure precautions due to the risk of hepatic encephalopathy.

A patient with advanced cirrhosis is experiencing increasing lethargy and disorientation due to hepatic encephalopathy, alongside a confirmed diagnosis of spontaneous bacterial peritonitis (SBP). Which nursing intervention should be prioritized to address the patient's current condition and prevent further complications?

A) Administer lactulose to reduce blood ammonia levels.

B) Increase diuretic therapy to manage ascites.

C) Initiate a high-protein diet to improve nutritional status.

D) Encourage early ambulation to prevent immobility complications.

A patient with advanced cirrhosis is being monitored for hepatic encephalopathy and possible hepatorenal syndrome. Despite ongoing treatment, the patient shows marginal improvement. Which nursing intervention is most critical in managing this patient’s current condition?

A) Administering lactulose to decrease serum ammonia levels.

B) Increasing fluid intake to enhance renal perfusion.

C) Encouraging ambulation to improve respiratory function.

D) Initiating a high-protein diet to support liver function.

A patient with advanced cirrhosis is being monitored for hepatic encephalopathy and hypotension. The healthcare team is considering an albumin infusion to improve hemodynamic stability. What is the primary nursing consideration when administering albumin to this patient?

A) Monitor the patient for signs of fluid overload, such as peripheral edema and respiratory distress.

B) Assess the patient's urine output every 8 hours to evaluate kidney function during albumin administration.

C) Observe for signs of increased intracranial pressure, such as changes in pupil size and reactivity.

D) Encourage the patient to increase oral fluid intake to support albumin therapy.

A patient with hepatic encephalopathy and signs of ascites is receiving spironolactone and furosemide. The patient's serum sodium level is 128 mEq/L. Which nursing intervention is most appropriate to address this electrolyte imbalance while managing the patient's fluid status?

B) Restrict the patient's fluid intake and review current medication effects.

A) Increase the dose of furosemide to promote diuresis and correct hyponatremia.

B) Restrict the patient's fluid intake and review current medication effects.

C) Administer hypertonic saline to rapidly correct the serum sodium level.

D) Increase the dose of lactulose to enhance ammonia excretion and improve mental status.

A patient with hepatic encephalopathy and ascites is experiencing worsening mental status and has developed hyponatremia (serum sodium level of 128 mEq/L). Which of the following nursing interventions should be prioritized to address the patient's current complications?

C) Initiating a fluid restriction protocol to help manage the patient's hyponatremia.

A) Administering a hypertonic saline infusion to correct the hyponatremia.

B) Increasing the dose of lactulose to further reduce blood ammonia levels.

C) Initiating a fluid restriction protocol to help manage the patient's hyponatremia.

D) Administering a bolus of normal saline to improve renal perfusion.

A patient with worsening portal hypertension and suspected esophageal varices requires an urgent esophagogastroduodenoscopy (EGD). The healthcare team is considering the addition of non-selective beta-blockers to the treatment plan. Which clinical finding would be most concerning and require further evaluation before initiating beta-blocker therapy?

B) Serum potassium of 3.0 mEq/L

C) Elevated ammonia level of 85 µmol/L

D) Reduced blood flow in the portal vein

A patient with worsening portal hypertension and hepatic encephalopathy presents with an INR of 2.0, elevated bilirubin, and low serum potassium. Which nursing intervention is most appropriate to address the risk of variceal bleeding in this patient?

D) Start non-selective beta-blockers to reduce portal pressure

A) Administer vitamin K to correct the INR

B) Initiate a low-sodium diet to manage ascites

C) Prepare for an esophagogastroduodenoscopy (EGD)

D) Start non-selective beta-blockers to reduce portal pressure

cirrhosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver injury, often from alcohol use or viral hepatitis, leads to repeated cycles of liver cell damage and repair. This results in fibrosis, where healthy liver tissue is replaced by scar tissue, disrupting normal liver function.

• Secondary mechanism: The fibrotic tissue alters liver architecture, causing portal hypertension due to increased resistance to blood flow. This pressure forces blood to find alternative pathways, leading to varices and potential bleeding.

• Key complication: Impaired liver function and portal hypertension can result in ascites, hepatic encephalopathy, and increased risk of infections due to compromised detoxification and protein synthesis abilities.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Chronic hepatitis C infection, alcohol use disorder (20 years, currently abstinent for 6 months), hypertension

• Current medications: Lisinopril 10 mg daily, Lactulose 30 mL twice daily, Spironolactone 100 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal discomfort and swelling

• Key symptoms: Fatigue, jaundice, peripheral edema, mild confusion

• Vital signs: Blood pressure 135/85 mmHg, heart rate 98 bpm, respiratory rate 18 breaths per minute, temperature 99.1°F, oxygen saturation 95% on room air

Section 1

As the healthcare team continues to assess the 58-year-old male with cirrhosis, initial assessment findings reveal further insights into his condition. On physical examination, the patient's abdomen is distended and tense, indicating significant ascites. Shifting dullness is present upon percussion, confirming fluid accumulation in the peritoneal cavity. The patient exhibits mild confusion, aligning with hepatic encephalopathy, likely due to the liver's impaired ability to detoxify ammonia. His sclera and skin show a deeper yellow hue, consistent with worsening jaundice. Peripheral edema is noted in the lower extremities, extending up to the knees, suggesting a progression of fluid retention.

Laboratory results return with notable abnormalities. His serum albumin is decreased at 2.5 g/dL, indicative of impaired synthetic function of the liver. The liver function tests show elevated total bilirubin at 4.2 mg/dL and elevated liver enzymes, with AST at 98 U/L and ALT at 85 U/L, reflecting ongoing hepatocellular injury. The patient's INR is prolonged at 1.8, hinting at compromised liver function affecting coagulation pathways. Additionally, ammonia levels are elevated at 80 µmol/L, correlating with the mental status changes observed.

Given these findings, the clinical team initiates a discussion on adjusting the management plan. The focus will be on optimizing diuretic therapy to manage ascites, considering potential paracentesis for symptomatic relief, and addressing hepatic encephalopathy by adjusting lactulose dosing and possibly introducing rifaximin. Furthermore, the team considers the need for vigilant monitoring for signs of spontaneous bacterial peritonitis, given the risk of infection associated with ascitic fluid accumulation. These interventions aim to stabilize the patient and improve his quality of life as the team plans the next steps in his care journey.

Section 2

As the healthcare team continues to monitor the patient, a change in his status becomes apparent. Over the course of the next 48 hours, the patient experiences increasing lethargy and disorientation, progressing from mild confusion to stupor. This escalation in his mental state suggests a worsening of hepatic encephalopathy, potentially due to inadequate ammonia detoxification despite the adjusted lactulose regimen. Vital signs reveal a blood pressure of 92/58 mmHg and a heart rate of 112 beats per minute, indicating possible hypovolemia or systemic infection. His respiratory rate is elevated at 22 breaths per minute, and he has developed a low-grade fever of 100.4°F (38°C).

In light of these developments, the team re-evaluates the patient's condition and considers the possibility of spontaneous bacterial peritonitis (SBP), a serious complication of cirrhosis. A diagnostic paracentesis is performed to obtain ascitic fluid for analysis. The results reveal an elevated white blood cell count with a polymorphonuclear leukocyte count of 350 cells/mm³, confirming the diagnosis of SBP. As a result, the team initiates empirical antibiotic therapy with intravenous cefotaxime to address the infection promptly.

The patient's deteriorating neurological status and the onset of SBP underscore the need for meticulous clinical reasoning. The team re-assesses the balance between diuretic therapy and fluid management to prevent further hemodynamic instability. Additionally, they discuss the potential need for more aggressive measures to control ammonia levels, such as increasing the dose of rifaximin. This comprehensive approach aims to stabilize the patient and prevent further complications, while also emphasizing the importance of ongoing monitoring and reassessment in the management of advanced cirrhosis.

Section 3

In the following 24 hours, the healthcare team closely monitors the patient's response to the antibiotic therapy and adjustments in his treatment regimen. Despite these interventions, the patient’s condition shows only marginal improvement. Repeat vital signs indicate persistent hypotension with a blood pressure of 90/54 mmHg and a heart rate still elevated at 110 beats per minute. His respiratory rate remains at 22 breaths per minute, and his temperature has slightly decreased to 99.8°F (37.7°C). However, his neurological status continues to be a concern, as he fluctuates between confusion and stupor, indicating ongoing hepatic encephalopathy.

Laboratory results reveal further insights into the patient’s condition. Serum ammonia levels remain elevated at 130 µmol/L (normal range: 15-45 µmol/L), indicating the need for enhanced measures to manage ammonia accumulation. Liver function tests show worsening hepatic impairment with increased total bilirubin at 5.5 mg/dL (normal range: 0.1-1.2 mg/dL), and decreased albumin levels at 2.0 g/dL (normal range: 3.5-5.0 g/dL). Additionally, there is a slight increase in creatinine to 1.4 mg/dL from a baseline of 1.0 mg/dL, suggesting possible renal involvement, which necessitates further evaluation for hepatorenal syndrome.

In response to these findings, the team deliberates on the effectiveness of the current therapeutic approach and considers the introduction of albumin infusion to improve hemodynamic stability and renal perfusion. They also discuss escalating the dose of rifaximin alongside lactulose to achieve better control of hepatic encephalopathy. The importance of vigilant monitoring is reiterated, as the patient’s stability hangs in a delicate balance, and the team prepares for potential escalation in care, including transfer to the intensive care unit if necessary. This ongoing assessment and adjustment of treatment strategies are critical in managing the complexities of advanced cirrhosis and its complications.

Section 4

New Complications

In the following hours, the patient's condition begins to deteriorate, marking the onset of new complications. Despite the initiation of albumin infusion and increased doses of rifaximin and lactulose, the patient's mental status worsens, with longer episodes of confusion and stupor. His Glasgow Coma Scale score drops to 10, indicating a significant decline in neurological function. Additionally, the patient develops signs of ascites, evidenced by abdominal distension and shifting dullness on percussion. This suggests worsening portal hypertension and fluid imbalance, which require immediate attention and the potential use of diuretics such as spironolactone and furosemide.

Laboratory results further complicate the clinical picture. The patient's serum sodium level falls to 128 mEq/L (normal range: 135-145 mEq/L), indicating hyponatremia, which may exacerbate hepatic encephalopathy and increase the risk of cerebral edema. The slight increase in creatinine observed earlier escalates to 1.8 mg/dL, raising concerns for acute kidney injury and progression toward hepatorenal syndrome. In light of these developments, the healthcare team decides to implement a more aggressive fluid management strategy, carefully balancing diuretics to manage ascites while monitoring renal function closely.

The healthcare team faces critical decisions as they navigate the complexities of these new complications. The patient's fragile condition necessitates a potential escalation of care, including consideration for transfer to the intensive care unit for closer monitoring and more intensive interventions such as renal replacement therapy if renal function continues to decline. This situation underscores the need for ongoing clinical reasoning, as the team works to balance the management of hepatic and renal complications while providing supportive care to prevent further deterioration.

Section 5

As the healthcare team continues to address the patient's deteriorating condition, a new set of diagnostic results arrives that further complicates the clinical picture. An ultrasound of the abdomen reveals moderate ascites and also highlights splenomegaly, confirming the suspicion of worsening portal hypertension. Additionally, Doppler studies indicate reduced blood flow in the portal vein, heightening the risk of variceal bleeding. The presence of esophageal varices is suspected, necessitating an urgent esophagogastroduodenoscopy (EGD) to assess and potentially manage this complication.

Laboratory results reveal further derangements. The patient's INR climbs to 2.0, indicating a decline in hepatic synthetic function and an increased risk of bleeding. Liver function tests show a marked elevation in bilirubin to 4.5 mg/dL (normal range: 0.1-1.2 mg/dL), alongside elevated AST and ALT levels, suggesting ongoing hepatic inflammation or injury. The patient's ammonia level remains elevated at 85 µmol/L (normal range: 15-45 µmol/L), correlating with his worsening encephalopathy. The hyponatremia persists, and serum potassium drops to 3.0 mEq/L (normal range: 3.5-5.0 mEq/L), prompting the need for careful electrolyte management to avoid further complications.

In response to these findings, the healthcare team considers adjusting the patient's treatment plan. The addition of non-selective beta-blockers is contemplated to manage portal hypertension and reduce the risk of variceal bleeding. The team must weigh the benefits of initiating such therapy against potential hemodynamic instability, especially considering the patient's tenuous renal status. Concurrently, close monitoring of the patient's neurological function and electrolyte levels is prioritized, with adjustments to lactulose and rifaximin dosages as needed to better control hepatic encephalopathy. These considerations demand thorough clinical reasoning and a collaborative approach to anticipate further complications and guide the next steps in the patient's care journey.